240 related articles for article (PubMed ID: 30022632)
21. The effect of body mass index on surgical outcomes and survival following pelvic exenteration.
Iglesias DA; Westin SN; Rallapalli V; Huang M; Fellman B; Urbauer D; Frumovitz M; Ramirez PT; Soliman PT
Gynecol Oncol; 2012 May; 125(2):336-42. PubMed ID: 22261299
[TBL] [Abstract][Full Text] [Related]
22. Overall survival after pelvic exenteration for gynecologic malignancy.
Westin SN; Rallapalli V; Fellman B; Urbauer DL; Pal N; Frumovitz MM; Ramondetta LM; Bodurka DC; Ramirez PT; Soliman PT
Gynecol Oncol; 2014 Sep; 134(3):546-51. PubMed ID: 25014540
[TBL] [Abstract][Full Text] [Related]
23. Characteristics of gynecologic oncology patients in King Chulalongkorn Memorial Hospital - complications and outcome of pelvic exenteration.
Oranratanaphan S; Termrungruanglert W; Sirisabya N
Asian Pac J Cancer Prev; 2013; 14(4):2529-32. PubMed ID: 23725169
[TBL] [Abstract][Full Text] [Related]
24. Pelvic Exenteration in Gynecologic Cancer: La Paz University Hospital Experience.
Moreno-Palacios E; Diestro MD; De Santiago J; Hernández A; Zapardiel I
Int J Gynecol Cancer; 2015 Jul; 25(6):1109-14. PubMed ID: 25853383
[TBL] [Abstract][Full Text] [Related]
25. Pelvic exenterations for gynecological malignancies: twenty-year experience at Roswell Park Cancer Institute.
Sharma S; Odunsi K; Driscoll D; Lele S
Int J Gynecol Cancer; 2005; 15(3):475-82. PubMed ID: 15882172
[TBL] [Abstract][Full Text] [Related]
26. Primary vaginal and pelvic floor reconstruction at the time of pelvic exenteration: a study of morbidity.
Jurado M; Bazán A; Elejabeitia J; Paloma V; Martínez-Monge R; Alcázar JL
Gynecol Oncol; 2000 May; 77(2):293-7. PubMed ID: 10785481
[TBL] [Abstract][Full Text] [Related]
27. Major complications following exenteration in cases of pelvic malignancy: a 10-year experience.
Wydra D; Emerich J; Sawicki S; Ciach K; Marciniak A
World J Gastroenterol; 2006 Feb; 12(7):1115-9. PubMed ID: 16534855
[TBL] [Abstract][Full Text] [Related]
28. Minimally Invasive Pelvic Exenteration for Gynecologic Malignancies: A Multi-Institutional Case Series and Review of the Literature.
Bizzarri N; Chiantera V; Ercoli A; Fagotti A; Tortorella L; Conte C; Cappuccio S; Di Donna MC; Gallotta V; Scambia G; Vizzielli G
J Minim Invasive Gynecol; 2019; 26(7):1316-1326. PubMed ID: 30611973
[TBL] [Abstract][Full Text] [Related]
29. A modern-day experience with Brunschwig's operation: Outcomes associated with pelvic exenteration.
Rios-Doria E; Filippova OT; Straubhar AM; Chi A; Awowole I; Sandhu J; Broach V; Mueller JJ; Gardner GJ; Jewell EL; Zivanovic O; Leitao MM; Long Roche K; Abu-Rustum NR; Sonoda Y
Gynecol Oncol; 2022 Nov; 167(2):277-282. PubMed ID: 36064678
[TBL] [Abstract][Full Text] [Related]
30. Complications after double-barreled wet colostomy compared to separate urinary and fecal diversion during pelvic exenteration: time to change back?
Backes FJ; Tierney BJ; Eisenhauer EL; Bahnson RR; Cohn DE; Fowler JM
Gynecol Oncol; 2013 Jan; 128(1):60-64. PubMed ID: 22892363
[TBL] [Abstract][Full Text] [Related]
31. Urological leaks after pelvic exenterations comparing formation of colonic and ileal conduits.
Teixeira SC; Ferenschild FT; Solomon MJ; Rodwell L; Harrison JD; Young JM; Vasilaras A; Eisinger D; Lee P; Byrne C
Eur J Surg Oncol; 2012 Apr; 38(4):361-6. PubMed ID: 22265840
[TBL] [Abstract][Full Text] [Related]
32. Pelvic exenteration: impact of age on surgical and oncologic outcomes.
Huang M; Iglesias DA; Westin SN; Fellman B; Urbauer D; Schmeler KM; Frumovitz M; Ramirez PT; Soliman PT
Gynecol Oncol; 2014 Jan; 132(1):114-8. PubMed ID: 24262877
[TBL] [Abstract][Full Text] [Related]
33. Ileal conduit and continent ileocecal pouch for patients undergoing pelvic exenteration: comparison of complications and quality of life.
Forner DM; Lampe B
Int J Gynecol Cancer; 2011 Feb; 21(2):403-8. PubMed ID: 22964492
[TBL] [Abstract][Full Text] [Related]
34. Continent urinary diversion and low-rectal anastomosis in patients undergoing exenterative procedures for recurrent gynecologic malignancies.
Husain A; Curtin J; Brown C; Chi D; Hoskins W; Poynor E; Alektiar K; Barakat R
Gynecol Oncol; 2000 Aug; 78(2):208-11. PubMed ID: 10926804
[TBL] [Abstract][Full Text] [Related]
35. Pelvic exenteration. Has it a role in 1987? A six year experience.
Shepherd JH
Verh K Acad Geneeskd Belg; 1989; 51(1):31-44; discussion 44-6. PubMed ID: 2800684
[TBL] [Abstract][Full Text] [Related]
36. [Urinary complications of pelvic exenterations for rectal cancer with urinary invasion].
Gas J; Beauval JB; Chalret du Rieu M; Bou Nasr E; Philis A; Kirzin S; Thoulouzan M; Soulié M; Ghouti L
Prog Urol; 2015 May; 25(6):348-54. PubMed ID: 25804429
[TBL] [Abstract][Full Text] [Related]
37. [Pelvic exenteration of advanced gynecological malignacies: a report of 18 cases].
Zhang Z; Zang R; Chen J
Zhonghua Fu Chan Ke Za Zhi; 2000 May; 35(5):288-90. PubMed ID: 11775910
[TBL] [Abstract][Full Text] [Related]
38. Improvements in pelvic exenteration: factors responsible for reducing morbidity and mortality.
Goldberg JM; Piver MS; Hempling RE; Aiduk C; Blumenson L; Recio FO
Ann Surg Oncol; 1998; 5(5):399-406. PubMed ID: 9718168
[TBL] [Abstract][Full Text] [Related]
39. Outcomes following repeat exenteration for locally advanced pelvic malignancy.
Blake J; Koh CE; Steffens D; De Robles MS; Brown K; Lee P; Austin K; Solomon MJ
Colorectal Dis; 2021 Mar; 23(3):646-652. PubMed ID: 33058495
[TBL] [Abstract][Full Text] [Related]
40. Pelvic exenteration for recurrent or persistent gynecologic malignancies: a 10-year review of the Memorial Sloan-Kettering Cancer Center experience (1972-1981).
Lawhead RA; Clark DG; Smith DH; Pierce VK; Lewis JL
Gynecol Oncol; 1989 Jun; 33(3):279-82. PubMed ID: 2722049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
